Literature DB >> 1327761

The Xmrk receptor tyrosine kinase is activated in Xiphophorus malignant melanoma.

J Wittbrodt1, R Lammers, B Malitschek, A Ullrich, M Schartl.   

Abstract

Xmrk encodes a putative transmembrane glycoprotein of the tyrosine kinase family and is a melanoma-inducing gene in Xiphophorus. We attempted to investigate the biological function of the putative Xmrk receptor by characterizing its signalling properties. Since a potential ligand for Xmrk has not yet been identified, it has been difficult to analyse the biochemical properties and biological function of this cell surface protein. In an approach towards such analyses, the Xmrk extracellular domain was replaced by the closely related ligand-binding domain sequences of the human epidermal growth factor receptor (HER) and the ligand-induced activity of the chimeric HER-Xmrk protein was examined. We show that the Xmrk protein is a functional receptor tyrosine kinase, is highly active in malignant melanoma and displays a constitutive autophosphorylation activity possibly due to an activating mutation in its extracellular or transmembrane domain. In the focus formation assay the HER-Xmrk chimera is a potent transforming protein equivalent to other tyrosine kinase oncoproteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327761      PMCID: PMC556935          DOI: 10.1002/j.1460-2075.1992.tb05518.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

Review 1.  Molecular cloning, structural characterization, and analysis of transcription of the melanoma oncogene of xiphophorus.

Authors:  M Schartl; D Adam
Journal:  Pigment Cell Res       Date:  1992

2.  Identification of a ligand for the c-kit proto-oncogene.

Authors:  D E Williams; J Eisenman; A Baird; C Rauch; K Van Ness; C J March; L S Park; U Martin; D Y Mochizuki; H S Boswell
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

Review 3.  Sevenless and Drosophila eye development: a tyrosine kinase controls cell fate.

Authors:  K Basler; E Hafen
Journal:  Trends Genet       Date:  1988-03       Impact factor: 11.639

4.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation.

Authors:  S Nishibe; M I Wahl; S M Hernández-Sotomayor; N K Tonks; S G Rhee; G Carpenter
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

7.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

8.  Expression of proto-oncogenes in embryonic, adult, and transformed tissue of Xiphophorus (Teleostei: Poeciliidae).

Authors:  W Mäueler; F Raulf; M Schartl
Journal:  Oncogene       Date:  1988-05       Impact factor: 9.867

9.  Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation.

Authors:  A Rosenthal; P B Lindquist; T S Bringman; D V Goeddel; R Derynck
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

10.  Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites.

Authors:  A Honegger; T J Dull; F Bellot; E Van Obberghen; D Szapary; A Schmidt; A Ullrich; J Schlessinger
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  12 in total

Review 1.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

2.  Melanoma loss-of-function mutants in Xiphophorus caused by Xmrk-oncogene deletion and gene disruption by a transposable element.

Authors:  M Schartl; U Hornung; H Gutbrod; J N Volff; J Wittbrodt
Journal:  Genetics       Date:  1999-11       Impact factor: 4.562

3.  Biological and biochemical activities of a chimeric epidermal growth factor-Elk receptor tyrosine kinase.

Authors:  V Lhoták; T Pawson
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

4.  Cooperative effects of INK4a and ras in melanoma susceptibility in vivo.

Authors:  L Chin; J Pomerantz; D Polsky; M Jacobson; C Cohen; C Cordon-Cardo; J W Horner; R A DePinho
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

5.  A single gene causes both male sterility and segregation distortion in Drosophila hybrids.

Authors:  Nitin Phadnis; H Allen Orr
Journal:  Science       Date:  2008-12-11       Impact factor: 47.728

Review 6.  [Model systems for investigation of genetic factors in tumorigenesis].

Authors:  M Schartl
Journal:  Naturwissenschaften       Date:  1995-05

7.  A putative marker for human melanoma. A monoclonal antibody derived from the melanoma gene in the Xiphophorus melanoma model.

Authors:  J R Vielkind; V A Tron; B M Schmidt; G J Dougherty; V C Ho; B W Woolcock; B Sadaghiani; C J Smith
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

8.  The macromelanophore locus and the melanoma oncogene Xmrk are separate genetic entities in the genome of Xiphophorus.

Authors:  S Weis; M Schartl
Journal:  Genetics       Date:  1998-08       Impact factor: 4.562

Review 9.  Melanoma biology and the promise of zebrafish.

Authors:  Craig J Ceol; Yariv Houvras; Richard M White; Leonard I Zon
Journal:  Zebrafish       Date:  2008-12       Impact factor: 1.985

10.  The Brn-2 transcription factor links activated BRAF to melanoma proliferation.

Authors:  Jane Goodall; Claudia Wellbrock; Timothy J Dexter; Karen Roberts; Richard Marais; Colin R Goding
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.